SAN FRANCISCO — SAN FRANCISCO — Nektar Therapeutics (NKTR) on Thursday reported a loss of $37.1 million in its third quarter. On a per-share basis, the San Francisco-based company said it had a loss ...
The average estimate of eight analysts surveyed by Zacks Investment Research was for earnings of 92 cents per share. The cloud-based phone system provider for small businesses posted revenue of $608.8 ...
"This quarter we have made progress against our key objectives and have seen meaningful progress on our Gen 2 R1 cost structure due to the new technologies incorporated into the vehicle and ...